Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Elliptinium acetate (NSC 264137), a DNA intercalating agent, exhibits high cytotoxicity towards L1210 cells and forms covalent bonds with nucleic acids from these cells. It holds potential in cancer research, especially for treating metastatic breast cancer.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | Elliptinium acetate (NSC 264137), a DNA intercalating agent, exhibits high cytotoxicity towards L1210 cells and forms covalent bonds with nucleic acids from these cells. It holds potential in cancer research, especially for treating metastatic breast cancer. |
Synonyms | NSC 264137, Celiptium, NSC 264137 ; Celiptium |
Molecular Weight | 336.38 |
Formula | C20H20N2O3 |
CAS No. | 58337-35-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Elliptinium acetate 58337-35-2 NSC 264137 Celiptium NSC 264137 ; Celiptium NSC-264137 NMHE NSC 264137 ; Celiptium HME 9HME NSC264137 Elliptinium Acetate inhibitor inhibit